Current status and prospects of antiplatelet therapy in percutaneous coronary intervention in Japan: Focus on adenosine diphosphate receptor inhibitors

被引：11
|
作者：
Ogawa, Hisao [1 ]
Hokimoto, Seiji [1 ]
Kaikita, Koichi [1 ]
Yamamoto, Koichiro [1 ]
Chitose, Tadasuke [1 ]
Ono, Takamichi [1 ]
Tsujita, Kenichi [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan
来源：
JOURNAL OF CARDIOLOGY | 2011年 / 58卷 / 01期
关键词：
Cardiovascular disease; Platelet inhibitors; Thrombosis; Drug therapy; Adenosine diphosphate; ELEVATION MYOCARDIAL-INFARCTION; ASPIRIN-TREATED PATIENTS; PROTON PUMP INHIBITORS; INDUCED HEPATOTOXICITY; STENT IMPLANTATION; DIABETES-MELLITUS; AMERICAN-COLLEGE; HEALTHY CHINESE; ARTERY-DISEASE; DOUBLE-BLIND;
D O I：
10.1016/j.jjcc.2011.03.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Dual antiplatelet therapy with aspirin and clopidogrel is routinely used to prevent thrombotic events in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) in Japan. However, these agents have various limitations and some patients will experience further cardiovascular events. The purpose of this article is to review the antiplatelet agents currently used in patients undergoing PCI in Japan, to discuss the issues and limitations associated with these antiplatelet agents, and to characterize new antiplatelet agents currently under investigation in Japan. Particular emphasis is placed on the novel thienopyridine prasugrel, and the potential this drug has for overcoming the issues associated with other antiplatelet agents. (C) 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：6 / 17
页数：12
相关论文
共 50 条
  • [21] The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and "Asian Paradox"
    Kang, Jeehoon
    Kim, Hyo-Soo
    KOREAN CIRCULATION JOURNAL, 2018, 48 (07) : 537 - 551
  • [22] Antiplatelet Therapy and Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia
    Yusuf, Syed Wamique
    Iliescu, Cezar
    Bathina, Jaya D.
    Daher, Iyad N.
    Durand, Jean-Bernard
    TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (03) : 336 - 340
  • [23] ANTIPLATELET THERAPY AND INFLAMMATORY STATUS ASSOCIATED WITH INTRA-STENT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
    Alexandrescu, D. M.
    Crisan, A.
    Mitu, O.
    Macovei, L.
    Costache, Irina Iuliana
    Mitu, Ivona
    Frasinariu, Otilia
    Alexandrescu, Anca
    Georgescu, Catalina Arsenescu
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2021, 125 (03): : 335 - 342
  • [24] Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: A potential antiplatelet therapeutic target
    Gurbel, Paul A.
    Antonino, Mark J.
    Bliden, Kevin P.
    DiChiara, Joseph
    Suarez, Thomas A.
    Singla, Anand
    Tantry, Udaya S.
    PLATELETS, 2008, 19 (08) : 595 - 604
  • [25] Effect of Blood Hematocrit and Erythrocyte Deformability on Adenosine 5′-Diphosphate Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy
    Cecchi, Emanuele
    Marcucci, Rossella
    Paniccia, Rita
    Bandinelli, Brunella
    Valente, Serafina
    Giglioli, Cristina
    Lazzeni, Chiara
    Gensini, Gian Franco
    Abbate, Rosanna
    Mannini, Lucia
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (06) : 764 - 768
  • [26] Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Price, Matthew J.
    Nayak, Keshav R.
    Barker, Colin M.
    Kandzari, David E.
    Teirstein, Paul S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (10) : 1339 - 1343
  • [27] Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
    Capodanno, Davide
    Milluzzo, Rocco P.
    Angiolillo, Dominick J.
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2019, 13
  • [28] Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Fioretti, Vincenzo
    Sperandeo, Luca
    Gerardi, Donato
    Di Fazio, Aldo
    Stabile, Eugenio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [29] Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention
    Galli, Mattia
    Ortega-Paz, Luis
    Franchi, Francesco
    Rollini, Fabiana
    Angiolillo, Dominick J.
    PHARMACOGENOMICS, 2022, 23 (13) : 723 - 737
  • [30] Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review
    Tang, Kevin S.
    Banerjee, Shoujit
    Tang, George
    Patel, Pranav M.
    Frangieh, Antonio H.
    INTERVENTIONAL CARDIOLOGY-REVIEWS RESEARCH RESOURCES, 2023, 18
12345